Neomycin, Sulfat (Salz)

Neomycin sulfate Struktur
1405-10-3
CAS-Nr.
1405-10-3
Bezeichnung:
Neomycin, Sulfat (Salz)
Englisch Name:
Neomycin sulfate
Synonyma:
NEOMYCIN SULPHATE;FRADIOMYCIN SULFATE;NeoMycin sulfat;neobiotic;neofracin;otobiotic;NeoMycin Trisulfate;NEOMYCIN SULFATE SALT;NEOMYCIN SULPHATE pure;Framycetin sulfate solution,100ppm
CBNumber:
CB0769897
Summenformel:
C23H48N6O17S
Molgewicht:
712.72
MOL-Datei:
1405-10-3.mol

Neomycin, Sulfat (Salz) Eigenschaften

Schmelzpunkt:
>187°C (dec.)
alpha 
D20 +54° (c = 2 in H2O)
Brechungsindex
56 ° (C=10, H2O)
Flammpunkt:
56℃
storage temp. 
2-8°C
Löslichkeit
H2O: 50 mg/mL As a stock solution. Stock solutions should be filter sterilized and stored at 2-8°C. Stable at 37°C for 5 days.
Aggregatzustand
powder
Farbe
white to slightly yellow
PH
5.0-7.5 (50g/l, H2O, 20℃)
Wasserlöslichkeit
Soluble in water
Merck 
14,6454
Stabilität:
Stable. Incompatible with strong oxidizing agents.
InChIKey
OIXVKQDWLFHVGR-VTSVPHRWSA-N
LogP
-3.655 (est)
CAS Datenbank
1405-10-3(CAS DataBase Reference)
EPA chemische Informationen
Neomycin sulfate (1405-10-3)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn,Xi
R-Sätze: 42/43-22
S-Sätze: 23-36/37-45-22-36-24/25
WGK Germany  3
RTECS-Nr. QP4375000
8
TSCA  Yes
HS Code  29419000
Toxizität LD50 oral in mouse: > 8gm
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H317 Kann allergische Hautreaktionen verursachen. Sensibilisierung der Haut Kategorie 1A Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
H334 Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen. Sensibilisierung der Atemwege Kategorie 1 Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" /> P261, P285, P304+P341, P342+P311,P501
Sicherheit
P261 Einatmen von Staub vermeiden.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P342+P311 Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.

Neomycin, Sulfat (Salz) Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R42/43:Sensibilisierung durch Einatmen und Hautkontakt möglich.
R22:Gesundheitsschädlich beim Verschlucken.

S-Sätze Betriebsanweisung:

S23:Gas/Rauch/Dampf/Aerosol nicht einatmen(geeignete Bezeichnung(en) vom Hersteller anzugeben).
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).
S22:Staub nicht einatmen.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
S24/25:Berührung mit den Augen und der Haut vermeiden.

Beschreibung

Neomycin sulfate is an aminoglycoside antibiotic and calcium channel protein inhibitor. Neomycin sulfate also binds to prokaryotic ribosomes inhibiting translation and is effective against gram-positive and gram-negative bacteria. Neomycin sulfate inhibits PLC (Phospholipase C) via binding to inositol phospholipids. It also inhibits phosphatidylcholine-PLD activity and induces Ca2+ mobilization and PLA2 activation in human platelets. Neomycin sulfate inhibits DNase I induced DNA degradation. It is used to prevent or treat skin infections caused by bacteria. It is not effective against fungal or viral infections.

Chemische Eigenschaften

White or yellowish-white powder; odorless; highly hygroscopic; aqueous solution exhibits dextrorotation. High solubility in water, while almost insoluble in ethanol, ether, acetone or chloroform.

Verwenden

Neomycin sulfate is an aminoglycoside antibiotic produced by S. fradiae that inhibits protein translation by binding to the small subunit of prokaryotic ribosomes. It blocks voltage-sensitive Ca2+ channels and is a potent inhibitor of skeletal muscle sarcoplasmic reticulum Ca2+ release. NEOMYCIN SULFATE has been shown to inhibit inositol phospholipid turnover, phospholipase C, and phosphatidylcholine-phospholipase D activity (IC50 = 65 μM). It is highly effective against Gram-positive and Gram-negative bacteria and is commonly used for the prevention of bacterial contamination of cell cultures.

Indications

This drug is obtained from species of the actinomycete Streptomyces and is an aminoglycoside antibiotic (as are streptomycin, gentamicin, and kanamycin) effective against most aerobic gram-negative organisms. Group A streptococci are relatively resistant. Neomycin acts to inhibit bacterial protein synthesis by irreversibly binding to the 30S subunit. It is responsible for a greater incidence of allergic contact sensitivity than any other topical antibiotic. This diagnosis often remains hidden, because morphologically the eruption is of a mild eczematous nature. Rarely, anaphylaxis may occur.

Weltgesundheitsorganisation (WHO)

Neomycin sulfate, a broad-spectrum antibiotic, was first isolated in 1949 and has subsequently been included in topical, oral and parenteral preparations. Its value in the treatment of diarrhoea is widely questioned although it is still contained in a number of widely available antidiarrhoeal preparations. In some countries the officially approved indications for oral preparations are restricted to the preparation of the bowel prior to surgery and the management of hepatic coma.

Allgemeine Beschreibung

Chemical structure: aminoglycoside

Kontakt-Allergie

Neomycin is an antibiotic complex of the aminoglycosides group, extracted from Streptomyces fradiae. It is composed of neomycin A (neamin) and an isomer neobiosamin, either neomycin B (framycetin or Soframycin?) or neomycin C. Its use has been progressively forbidden in cosmetics and as an additive for animal feed. Occupational contact dermatitis occurs in workers at animal feed mills, in veterinaries, or in health workers. Nonoccupational dermatitis mainly concerns patients with chronic dermatitis, leg ulcers, or chronic otitis. Cross-sensitivity is usual with other aminoglycosides (amikacin, arbekacin, butirosin, dibekacin, gentamicin, isepamicin, kanamycin, paromomycin, ribostamycin, sisomycin, tobramycin), is rare with netilmicin and streptomycin, but nonexistent with spectinomycin.

Clinical Use

In a search for antibiotics less toxic than streptomycin,Waksman and Lechevalier isolated neomycin (Mycifradin,Neobiotic) in 1949 from Streptomyces fradiae. Since then, theimportance of neomycin has increased steadily, and today, itis considered one of the most useful antibiotics for the treatmentof GI infections, dermatological infections, and acutebacterial peritonitis. Also, it is used in abdominal surgery toreduce or avoid complications caused by infections from bacterialflora of the bowel. It has broad-spectrum activityagainst various organisms and shows a low incidence of toxicand hypersensitivity reactions. It is absorbed very slightlyfrom the digestive tract, so its oral use ordinarily does not produce any systemic effect. The development of neomycinresistantstrains of pathogens is rarely reported in those organismsagainst which neomycin is effective.
Neomycin as the sulfate salt is a white to slightly yellow,crystalline powder that is very soluble in water. It is hygroscopicand photosensitive (but stable over a wide pH rangeand to autoclaving). Neomycin sulfate contains the equivalentof 60% of the free base.
Neomycin, as produced by S. fradiae, is a mixture ofclosely related substances. Included in the “neomycin complex”is neamine (originally designated neomycin A) andneomycins B and C. S. fradiae also elaborates another antibiotic,the fradicin, which has some antifungal propertiesbut no antibacterial activity. This substance is not present in“pure” neomycin.

Nebenwirkungen

The most common adverse reactions to oral neomycin sulfate are nausea, vomiting and diarrhea. The “Malabsorption Syndrome” characterized by increased fecal fat, decreased serum carotene and fall in xylose absorption has been reported with prolonged therapy.

Sicherheitsprofil

Poison by intramuscular, intravenous, and subcutaneous routes. Human systemic effects by ingestion: somnolence, hallucinations and distorted perceptions, and anorexia. A human skin irritant. When heated to decomposition it emits very toxic fumes of SOx.

Neomycin, Sulfat (Salz) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Neomycin, Sulfat (Salz) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 773)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Baoji Guokang Bio-Technology Co., Ltd.
0917-3909592 13892490616
gksales1@gk-bio.com China 9338 58
APOLLO HEALTHCARE RESOURCES
+6596580999
sales@apollo-healthcare.com.sg Singapore 400 58
Hubei Harvest Chemical CO.,Ltd
+86-13129915771 +86-15623179893
wendy@hb-harvestchem.com China 931 58
XI AN SGONEK BIOLOGICAL TECHNOLOGY CO., LTD
15202951039
jason@sgonekbio.com China 268 58
Wuhan Marco Pharmaceutical Technology Co., Ltd.
+86-86-18572802410 +8618572802410
sales@marcopht.com China 55 58
Hebei Yime New Material Technology Co., Ltd.
+86-66697723 +86-17703311139
admin@china-yime.com China 563 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618740459177
sarah@tnjone.com China 958 58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com China 992 58
shandong perfect biotechnology co.ltd
+86-53169958659; +8618596095638
sales@sdperfect.com China 294 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971
deasea125996@gmail.com China 2503 58

1405-10-3(Neomycin, Sulfat (Salz))Verwandte Suche:


  • mycigient
  • neo-mantlecreme
  • neomix
  • neomycinesulfate
  • newfrancef
  • O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy sulfate
  • Dentargle
  • Neomycin/sulfuric acid
  • Tilmicosin (FDA)
  • Neomycin hydrate trisulfate salt
  • Neomycin sulfate 100mg [1405-10-3]
  • NEOMYCIN.SULFATE RESEARCH GRADE
  • NEOMYCIN SULFATE
  • NEOMYCIN SULFATE, GAMMA-IRRADIATED
  • biosolveterinary
  • bykomycin
  • lidamycincreme
  • mycaifradinsulfate
  • mycifradin-n
  • Neomycin Sulfate (200 mg)
  • NeoMycin sulphate COS
  • 2'-DEOXYGUANOSINE MONOHYDRATE ULTRA PURE
  • Neomycin Sulfate, γ-Irradiated, Tissue Culture Grade
  • Neomyacin B sulfate
  • Neomyacin sulfate
  • Neomycin sulfate, for microbiological assay
  • Framycetin sulfate solution,1000ppm
  • Neomycin trisulfate salt
  • quintess-n
  • usafcb-19
  • NEOMYCIN TRISULFATE SALT HYDRATE, BIOTEC
  • NEOMYCIN SULFATE CELL CULTURE TESTED
  • NEOMYCIN SULFATE PLANT CELL*CULTURE TEST ED
  • NEOMYCIN SOLUTION CELL CULTURE TESTED
  • NEOMYCIN SULFATE CELL CULTURE REAGENT
  • NeomycinSulphatePurissForBacteriology
  • NEOMYCIN SULPHATE FOR BACTERIOLOGY
  • NeomycinesulfateTrisulfateSaltHydrate
  • Fradiomycin Trisulfate Hydrate
  • Endomixin
  • Myacine
  • Mycerin sulfate
  • Myciguent
  • Neobrettin
  • Neosulf
  • Tuttomycin
  • FRADIOMYCINSULPHATE
  • NEOMYCINESULPHATE
  • NEOMYCIN SULFATE USP BP GRADE
  • Mycifradin sulfate
  • Neomycin Sulfate - CAS 1405-10-3 - Calbiochem
  • Neomycin Sulfate, γ-Irradiated, Tissue Culture Grade - CAS 1405-10-3 - Calbiochem
  • Neomycin Sulfate Tablets
  • Neomycin trisulfate hydrate(Technical)
  • NEOMYCIN, GAMMA IRRADIATED
  • Neomysin Sulphate
  • (2RS,3S,4S,5R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3S,4R,5S)-5-((1R,2R,5R,6R)-3,5-DIAMINO-2-((2R,3S,4R,5S)-3-AMINO-6-(AMINOMETHYL)-4,5-DIHYDROXYTETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-4-HYDROXY-2-(HYDROXYMETHYL)TETRAHYDROFURAN-3-YLOXY)TETRAHYDRO-2H-PYRAN-3,4-DIOL
  • Neomycin sulfate, an aminoglycoside antibiotic and calcium channel protein inhibitor
Copyright 2019 © ChemicalBook. All rights reserved